BINV — BioInvent International AB Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapMomentum Trap

Annual balance sheet for BioInvent International AB, fiscal year end - December 31st, SEK millions except per share, conversion factor applied.

	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st	2024 December 31st
Period Length:	—	—	—	—	—
Source:	ARS	ARS	ARS	ARS	ARS
Standards:	IFRS	IFRS	IFRS	IFRS	IFRS
Status:	Final	Final	Final	Final	Final
Cash
Short Term Investments
Cash and Short Term Investments	729	1,083	1,017	1,069	867
Net Total Accounts Receivable
Net Total Receivables	35.5	9.39	36.6	32.7	25.2
Total Inventory
Prepaid Expenses
Total Current Assets	773	1,116	1,084	1,133	943
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	29.6	49.1	52	52.7	46
Net Intangible Assets
Long Term Investments
Total Assets	803	1,447	1,712	1,400	989
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Current Portion of Long Term Debt / Capital Leases
Total Other Current Liabilities
Total Current Liabilities	53.5	58.8	87.3	75.9	95.2
Capital Lease Obligations
Total Long Term Debt
Total Debt
Total Liabilities	59.1	80.3	106	90.5	103
Common Stock
Retained Earnings (Accumulated Deficit)
Other Equity
Total Equity	743	1,367	1,606	1,310	886
Total Liabilities & Shareholders' Equity	803	1,447	1,712	1,400	989
Total Common Shares Outstanding